GSK-202007

Study Sponsor: GSK

Study Title

A Double-Blind, Placebo-Controlled, Dose-Escalation, First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects

Medicine or Vaccine (generic name)

GSK3389404

Sponsor Identification Number

202007

Trial Registry Identification Number(#'s)

NCT02647281

Medical Condition

Hepatitis B

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=202007

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02647281

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

April 2019